The Trump administration has struck a deal with drugmakers Eli Lilly and Novo Nordisk to offer versions of their breakthrough weight-loss medications at steep discounts for certain Medicare and Medic...

President Donald Trump unveiled a deal Thursday with drugmakers Eli Lilly and Novo Nordisk to expand coverage and reduce prices for their popular obesity treatments Zepbound and Wegovy.

Privately, he has insisted that any savings on GLP-1 drugs should be one of the first announcements made as part of that campaign, according to two people involved in negotiations who spoke on the co...